Elicio Therapeutics (ELTX) Interest Expenses (2022 - 2026)
Elicio Therapeutics posted quarterly Interest Expenses of $407000.0 for Q1 2026, up 131.25% year-on-year from $176000.0 in Q1 2025, and up 20.77% on a QoQ basis from $337000.0 in Q4 2025.
Elicio Therapeutics (ELTX) has 5 years of Interest Expenses data on file, last reported at $407000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 131.25% year-over-year to $407000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 128.86% YoY), and the FY2025 full-year result was $1.1 million, up 149.01% from the prior year.
- Interest Expenses for Q1 2026 stood at $407000.0, up from $337000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.1 million in Q3 2022 and bottomed at $1000.0 in Q3 2023.
- The 5-year median for Interest Expenses is $214000.0 (2024), against an average of $330750.0.
- The widest annual swing landed in 2023, when Interest Expenses tumbled 99.91%; it then soared 13600.0% in 2024.
- A 5-year view of Interest Expenses shows it stood at $92000.0 in 2022, then sank by 97.83% to $2000.0 in 2023, then surged by 11600.0% to $234000.0 in 2024, then jumped by 44.02% to $337000.0 in 2025, then rose by 20.77% to $407000.0 in 2026.
- The last three Interest Expenses figures came in at $407000.0 (Q1 2026), $337000.0 (Q4 2025), and $426000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 407,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407,000.00 |
| Mar 31, 2026 | 407,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 714,000.00 |
| Jun 30, 2023 | 714,000.00 |
| Mar 31, 2023 | 342,000.00 |
| Mar 31, 2023 | 342,000.00 |
| Dec 31, 2022 | 92,000.00 |
| Dec 31, 2022 | 92,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |